<div><div></div><div><span><p><strong><span>Pulse Biosciences appointed Liane R. Teplitsky as Chief Operating Officer, effective April 8, 2026.</span></strong></p><div><table><tbody><tr><td><span>Individual</span></td><td><span>Liane R. Teplitsky</span></td></tr><tr><td><span>Role</span></td><td><span>Chief Operating Officer</span></td></tr><tr><td><span>Type of Change</span></td><td><span>Appointed</span></td></tr><tr><td><span>Effective Date</span></td><td><span>April 8, 2026</span></td></tr><tr><td><span>Reason</span></td><td><span>Not disclosed</span></td></tr><tr><td><span>Replacement Info</span></td><td><span>Not disclosed</span></td></tr><tr><td><span>Background Details</span></td><td><span>Former CEO of Artedrone; senior roles at Abbott Laboratories, St. Jude Medical; President of Robotics, Technology and Data Solutions at Zimmer Biomet; MS Biomedical Engineering (Duke); BS Electrical Engineering &amp; Physiology (Univ. of Saskatchewan); Chairman of Carvolix</span></td></tr><tr><td><span>Board/Committee Role Changes</span></td><td><span>Will remain Chairman of the Board of Carvolix; no other changes disclosed</span></td></tr></tbody></table></div><p><span>Original SEC Filing: </span>PULSE BIOSCIENCES, INC. [ PLSE ] - 8-K - Apr. 09, 2026</p><section><b><span class="heading-aHOVUrmQ">Disclaimer</span></b><div><span>This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.</span></div></section></span></div></div>

CVAC

<p>Pulse Biosciences has appointed Liane R. Teplitsky as Chief Operating Officer, effective April 8, 2026. Teplitsky has a strong background, having served as the former CEO of Artedrone and held senior roles at Abbott Laboratories and St. Jude Medical. She will also continue as Chairman of the Board of Carvolix. Further details regarding the reason for her appointment and any replacements have not been disclosed.</p>

TradingView

iShares US Pharma

Health Care Select Sector SPDR

CureVac BV

Direxion S&P Biotech Bull 3X

Invesco Nasdaq Biotechnology ETF

VanEck Biotech ETF

iShares US Medical Devices

Corvus Pharma

Invesco Biotechnology & Genome ETF

iShares Biotechnology ETF

iShares Global Healthcare

VG Health

Ark Genomic Revolution ETF

First Trust NYSE Arca Biotech Index Fd

ALPS Medical Breakthrough

Proshares Ultra Nasdaq Biotech

Liane R. Teplitsky named Chief Operating Officer at Pulse Biosciences